| |
| Device | MagtraceTM and Sentimag(R) Magnetic Locatization System |
| Generic Name | Lymph node location system during sentinel biopsy procedure |
| Applicant | Endomagnetics Ltd., 330 Cambridge Science Park Milton Rd. Cambridge CB4 0WN |
| PMA Number | P160053 |
| Supplement Number | S002 |
| Date Received | 08/30/2018 |
| Decision Date | 12/06/2022 |
| Product Code |
PUV |
| Docket Number | 22M-3128 |
| Notice Date | 12/08/2022 |
| Advisory Committee |
General & Plastic Surgery |
| Supplement Type | Panel Track |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | Yes |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approved to assist in localizing lymph nodes draining a tumor site, as part of a sentinel lymph node biopsy procedure, in patients with breast cancer undergoing a mastectomy or lumpectomy. For patients undergoing lumpectomy, nipple sparing, nipple areolar sparing or skin sparing procedures, Magtrace is indicated to be injected only peritumorally. |
| Approval Order | Approval Order |
| Summary | Summary of Safety and Effectiveness |
| Labeling | Labeling Labeling Part 2 |
| Post-Approval Study | Show Report Schedule and Study Progress |